1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
W. P. Carey Inc. priced a €1.0 billion offering of senior unsecured notes with a weighted-average coupon of 3.500% and a weighted-average term of 7.4 years, with settlement expected February 24, 2026. The company said it will use the proceeds to repay €500 million of 2.250% notes due April 2026 and for general corporate purposes, including repaying amounts outstanding under its revolving credit facility and term loan.
Two tranches of €500 million each: 3.250% notes due 2031, offered at 99.249% of principal, and 3.750% notes due 2035, offered at 98.500% of principal
Proceeds to repay all €500 million of 2.250% Senior Notes due April 2026, plus general corporate purposes and other debt repayment
Expected settlement date February 24, 2026, subject to customary closing conditions
Cantor Equity Partners VI, Inc. completed its initial public offering of 11.5 million Class A ordinary shares at $10.00 per share on February 6, 2026, raising $115 million in gross proceeds. The full $115 million was placed in a U.S.-based trust account, and the company said the audited balance sheet as of that date is filed as Exhibit 99.1. The company is a blank-check company that has not yet commenced operations or identified a business combination, so shareholder value depends on whether it completes a future deal.
IPO of 11,500,000 Class A ordinary shares at $10.00 per share, including 1,500,000 shares from the full exercise of the underwriter's over-allotment option, closed February 6, 2026
Private placement of 300,000 Class A ordinary shares to sponsor Cantor EP Holdings VI, LLC at $10.00 per share, for $3 million in gross proceeds
$115 million ($10.00 per public share) placed in trust account with Continental Stock Transfer & Trust Company as trustee; offering costs were approximately $2.5 million
Company has until February 6, 2028 to complete a business combination, or it must redeem public shares
Vail Resorts subsidiary Vail Holdings entered into a Tenth Amended and Restated Credit Agreement on February 9, 2026, with Bank of America as administrative agent. The new $1.275 billion senior term loan replaces the existing term loan and a $275 million delayed draw term loan, extends maturities, and lowers borrowing interest rates.
New $1,275,000,000 senior term loan facility replaces existing term loan (about $885.9 million outstanding) and $275,000,000 delayed draw term loan
Revolver and term loan maturities extended to the earlier of five years from closing or 90 days before the 5.625% senior notes due 2030 mature, if those notes remain outstanding
Borrowing interest rate reduced by modifying the leverage-based pricing grid and removing the 0.10% credit spread adjustment
Thermo Fisher issued four series of senior notes in a public offering on February 12, 2026, totaling $3.8 billion in principal. The company expects net proceeds of about $3.76 billion and plans to use them to pay part of the cash consideration for its pending Clario Acquisition, which still requires customary closing conditions and regulatory approvals.
Four note series totaling $3.8 billion: $1.0 billion due 2031, $750 million due 2033, $1.3 billion due 2036 and $750 million due 2046
Expected net proceeds of approximately $3.76 billion after underwriting discounts and estimated offering expenses
Proceeds intended to pay a portion of the cash consideration for the previously announced Clario Acquisition, which is subject to closing conditions and regulatory approvals
On February 12, 2026, CVR Energy issued $600 million of 7.500% senior notes due 2031 and $400 million of 7.875% senior notes due 2034 in a private offering. The company also amended its senior secured asset-based revolving credit facility, extending its maturity from June 2027 to February 2031 and raising commitments from $345 million to $550 million. The new notes add $1 billion of debt for shareholders to weigh against the larger borrowing capacity.
$600 million of 7.500% senior notes due February 15, 2031, and $400 million of 7.875% senior notes due February 15, 2034
Credit facility maturity extended from June 2027 to February 2031; commitments raised from $345 million to $550 million, with possible increase to $700 million
Notes are senior unsecured and guaranteed by most existing domestic subsidiaries; interest is payable semi-annually starting August 15, 2026
Holders may require repurchase at 101% of principal upon a change of control triggering event
BioMarin closed an $850 million private offering of 5.500% senior notes on February 12, 2026. The proceeds are held in escrow to help fund its pending acquisition of Amicus Therapeutics, alongside new term loans and a revolving credit facility.
$850 million of 5.500% senior unsecured notes due 2034 issued at 100.000% of face value
Proceeds held in escrow; notes must be redeemed at issue price plus accrued interest if the Amicus acquisition is not completed by December 19, 2026
Acquisition financing also includes a $2 billion term loan B, an $800 million term loan A and a $600 million revolving credit facility
Hennessy Capital Investment Corp. VIII, a blank check company, filed an audited balance sheet dated February 6, 2026, the day its $241.5 million initial public offering closed. The filing confirms the proceeds were deposited into a U.S. trust account, which holds funds for a future business combination or redemption of public shares.
IPO of 24.15 million units at $10.00 per unit, including 3.15 million units from the full over-allotment option, closed February 6, 2026
Private placement of 671,000 units to sponsor HC VIII Sponsor LLC generated $6.71 million
$241.5 million placed in trust account with Odyssey Transfer and Trust Company; deferred underwriting fee of $4.83 million
Company has 24 months from the IPO closing to complete an initial business combination and had not selected a target
Disney entered into an underwriting agreement on February 10, 2026 to sell $4 billion of notes in four tranches: floating rate notes due 2029, 3.750% notes due 2029, 4.000% notes due 2031, and 4.625% notes due 2036. The notes are registered under a previously filed Form S-3 and were issued under a 2019 indenture. The filing is mainly administrative, but it shows new borrowing that adds to the company's debt obligations.
Total offering of $4 billion: $500 million floating rate notes due 2029, $1 billion 3.750% notes due 2029, $1.5 billion 4.000% notes due 2031, and $1 billion 4.625% notes due 2036
Underwriters are Citigroup Global Markets Inc. and J.P. Morgan Securities LLC; agreement dated February 10, 2026
Officer's certificates establishing the notes are dated February 12, 2026; trustee is Citibank, N.A.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.